Literature DB >> 2188109

Characterization of chicken c-ski oncogene products expressed by retrovirus vectors.

P Sutrave1, T D Copeland, S D Showalter, S H Hughes.   

Abstract

We constructed replication-competent avian retrovirus vectors that contain two of the three known types of chicken c-ski cDNAs and a third vector that contains a truncated c-ski cDNA. We developed antisera that recognize the c-ski proteins made by the three transforming c-ski viruses. All three proteins (apparent molecular masses, 50, 60, and 90 kilodaltons) are localized primarily in the nucleus. The proteins are differentially phosphorylated; immunofluorescence also suggests that there are differences in subnuclear localization of the c-ski proteins and that c-ski protein is associated with condensed chromatin in dividing cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2188109      PMCID: PMC360678          DOI: 10.1128/mcb.10.6.3137-3144.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  16 in total

1.  Polyproteins containing a domain encoded by the V-SKI oncogene are located in the nuclei of SKV-transformed cells.

Authors:  A E Barkas; D Brodeur; E Stavnezer
Journal:  Virology       Date:  1986-05       Impact factor: 3.616

2.  Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.

Authors:  T D Copeland; W P Tsai; Y D Kim; S Oroszlan
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

3.  Phosphorylation of a cytosolic 65-kDa protein induced by interleukin 1 in glucocorticoid pretreated normal human peripheral blood mononuclear leukocytes.

Authors:  K Matsushima; Y Kobayashi; T D Copeland; T Akahoshi; J J Oppenheim
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

4.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

5.  Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors.

Authors:  S H Hughes; J J Greenhouse; C J Petropoulos; P Sutrave
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

6.  Transforming Sloan-Kettering viruses generated from the cloned v-ski oncogene by in vitro and in vivo recombinations.

Authors:  E Stavnezer; A E Barkas; L A Brennan; D Brodeur; Y Li
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

7.  Requirement of protein co-factor for the DNA-binding function of the human ski proto-oncogene product.

Authors:  T Nagase; G Mizuguchi; N Nomura; R Ishizaki; Y Ueno; S Ishii
Journal:  Nucleic Acids Res       Date:  1990-01-25       Impact factor: 16.971

8.  Molecular cloning and characterization of avian sarcoma virus circular DNA molecules.

Authors:  W J DeLorbe; P A Luciw; H M Goodman; H E Varmus; J M Bishop
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

9.  Generation of transforming viruses in cultures of chicken fibroblasts infected with an avian leukosis virus.

Authors:  E Stavnezer; D S Gerhard; R C Binari; I Balazs
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

10.  Unique sequence, ski, in Sloan-Kettering avian retroviruses with properties of a new cell-derived oncogene.

Authors:  Y Li; C M Turck; J K Teumer; E Stavnezer
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

View more
  14 in total

1.  Replication-competent retrovirus vectors for the transfer and expression of gene cassettes in avian cells.

Authors:  C J Petropoulos; S H Hughes
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Activation of the c-ski oncogene by overexpression.

Authors:  C Colmenares; P Sutrave; S H Hughes; E Stavnezer
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

3.  C-ski cDNAs are encoded by eight exons, six of which are closely linked within the chicken genome.

Authors:  H L Grimes; B E Szente; M M Goodenow
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

4.  Identification of Ski as a target for Aurora A kinase.

Authors:  Jocelyn Mosquera; Ricardo Armisen; Hongling Zhao; Diego A Rojas; Edio Maldonado; Julio C Tapia; Alicia Colombo; Michael J Hayman; Katherine Marcelain
Journal:  Biochem Biophys Res Commun       Date:  2011-05-12       Impact factor: 3.575

5.  Transformation of hematopoietic cells by the Ski oncoprotein involves repression of retinoic acid receptor signaling.

Authors:  R Dahl; M Kieslinger; H Beug; M J Hayman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

6.  DNA binding and transcriptional activation by the Ski oncoprotein mediated by interaction with NFI.

Authors:  P Tarapore; C Richmond; G Zheng; S B Cohen; B Kelder; J Kopchick; U Kruse; A E Sippel; C Colmenares; E Stavnezer
Journal:  Nucleic Acids Res       Date:  1997-10-01       Impact factor: 16.971

7.  Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.

Authors:  W Xu; K Angelis; D Danielpour; M M Haddad; O Bischof; J Campisi; E Stavnezer; E E Medrano
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

8.  Defective T-cell activation is associated with augmented transforming growth factor Beta sensitivity in mice with mutations in the Sno gene.

Authors:  S Pearson-White; M McDuffie
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

9.  Degeneration of skeletal and cardiac muscles in c-myb transgenic mice.

Authors:  Y Furuta; S Aizawa; Y Suda; Y Ikawa; H Nakasgoshi; Y Nishina; S Ishii
Journal:  Transgenic Res       Date:  1993-07       Impact factor: 2.788

10.  Factors of transforming growth factor beta signalling are co-regulated in human hepatocellular carcinoma.

Authors:  Thomas Longerich; Kai Breuhahn; Margarete Odenthal; Katharina Petmecky; Peter Schirmacher
Journal:  Virchows Arch       Date:  2004-09-29       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.